BMO Capital raised the firm’s price target on Exelon (EXC) to $50 from $46 and keeps an Outperform rating on the shares ahead of its Q1 results this week. Investors will be looking for thoughts and impacts of the recently-passed Maryland legislation codifying MYRPs but without reconciliations as well as other macro themes including tariffs, related sales impacts, and data center activity, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXC: